Trials / Completed
CompletedNCT04368338
Lung Ultrasound to Diagnose COVID-19
Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | COVID-19 RT-PCR | Polymerase chain reaction tests after reverse transcription for the detection of viral Covid-19 RNA (RT-PCR) |
| PROCEDURE | lung ultrasound | lung ultrasound is standard practice to diagnose acute respiratory failure in Emergency room |
Timeline
- Start date
- 2020-04-28
- Primary completion
- 2021-01-28
- Completion
- 2021-07-20
- First posted
- 2020-04-29
- Last updated
- 2021-07-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04368338. Inclusion in this directory is not an endorsement.